The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions

• Published in: International journal of pharmaceutics 2024-04, Vol.655, p.124055-124055, Article 124055
• Main Authors: Prašnikar, Monika, Proj, Matic, Bjelošević Žiberna, Maja, Lebar, Blaž, Knez, Benjamin, Kržišnik, Nika, Roškar, Robert, Gobec, Stanislav, Grabnar, Iztok, Žula, Aleš, Ahlin Grabnar, Pegi
• Format: Article
• Language: English
• Subjects: High concentration; Monoclonal antibodies; Proline analogs; Subcutaneous administration; Viscosity reducers
• ISSN: 0378-5173; 1873-3476
• DOI: 10.1016/j.ijpharm.2024.124055

[Display omitted] •Electrostatic interactions mainly contribute to the viscosity of protein solutions.•Novel proline-based compounds reduce the viscosity of monoclonal antibody solution.•These viscosity reducers do not jeopardise the stability of the protein.•Novel viscosity-reducing agents appear to be non-toxic, thus useful as excipients. Administration of monoclonal antibodies (mAbs) is currently focused on subcutaneous injection associated with increased patient adherence and reduced treatment cost, leading to sustainable healthcare. The main bottleneck is low volume that can be injected, requiring highly concentrated mAb solutions. The latter results in increased solution viscosity with pronounced mAb aggregation propensity because of intensive protein-protein interactions. Small molecule excipients have been proposed to restrict the protein-protein interactions, contributing to reduced viscosity. The aim of the study was to discover novel compounds that reduce the viscosity of highly concentrated mAb solution. First, the chemical space of proline analogs was explored and 35 compounds were determined. Viscosity measurements revealed that 18 proline analogs reduced the mAb solution viscosity similar to or more than proline. The compounds forming both electrostatic and hydrophobic interactions with mAb reduced the viscosity of the formulation more efficiently without detrimentally effecting mAb physical stability. A correlation between the level of interaction and viscosity-reducing effect was confirmed with molecular dynamic simulations. Structure rigidity of the compounds and aromaticity contributed to their viscosity-reducing effect, dependent on molecule size. The study results highlight the novel proline analogs as an effective approach in viscosity reduction in development of biopharmaceuticals for subcutaneous administration.